Empiric management of community-acquired pneumonia in Australian emergency departments

Medical Journal of Australia

Volumn 183, Issue 10, 2005, Pages 520-524

  Maxwell, David J ^a   McIntosh, Kylie A ^b   Pulver, Lisa K ^c   Easton, Kylie L ^d   Kaye, Karen ^a   Tett, Susan ^c   Coombes, Judith ^c   Petrie, Andrew ^c   Robertson, Marion ^b   Jamshidi, Nazila ^b   Dollman, William ^e   Marwood, Anita ^e   O'Connor, Peter ^e   Peterson, Greg ^f   Stanton, Lisa ^f   Wai, Angela ^c   Mackson, Judith ^c   Weekes, Lynn ^c  

^a NSW Therapeutic Advisory Group   (Australia)

^b Victorian Drug Usage Advisory Committee   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d National Prescribing Service Limited   (Australia)

^e DEPARTMENT OF HUMAN SERVICES   (Australia)

^f UNIVERSITY OF TASMANIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; CEFACLOR; CEFALEXIN; CEFALOTIN; CEFAZOLIN; CEFOTAXIME; CEFTRIAXONE; CEFUROXIME; CLARITHROMYCIN; DOXYCYCLINE; ERYTHROMYCIN; GATIFLOXACIN; GENTAMICIN; IMIPENEM; MACROLIDE; MEROPENEM; METRONIDAZOLE; MOXIFLOXACIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; ROXITHROMYCIN; TIMENTIN; TRIMETHOPRIM; UNINDEXED DRUG; VANCOMYCIN;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; AUSTRALIA; COMMUNITY ACQUIRED PNEUMONIA; DISEASE SEVERITY; DRUG ADMINISTRATION ROUTE; DRUG CHOICE; EMERGENCY WARD; EMPIRICISM; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HOSPITAL PATIENT; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOMES RESEARCH; PENICILLIN ALLERGY; PRACTICE GUIDELINE; PRESCRIPTION;

EID: 28444435432     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2005.tb07153.x     Document Type: Article

References (25)

1. File TM Jr, Garau J, Blasi F, et al. Guidelines for empiric antimicrobial prescribing in community-acquired pneumonia. Chest 2004; 125: 1888-1901.
2. Ball P, Baquero F, Cars O, et al. Antibiotic therapy of community respiratory tract infections: strategies for optimal outcomes and minimized resistance emergence. J Antimicrob Chemother 2002; 49: 31-40.
3. Johnson PD, Irving LB, Turnidge JD. 3: Community-acquired pneumonia. Med J Aust 2002; 176: 341-347.
4. Tsirgiotis E, Ruffin R. Community-acquired pneumonia. A perspective for general practice. Aust Fam Physician 2000; 29: 639-645.
5. Niederman MS, Mandell LA, Anzueto A, et al. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 2001; 163: 1730-1754.
6. Antibiotic Writing Group. Therapeutic guidelines: antibiotic. Version 12. Melbourne: Therapeutic Guidelines Limited, 2003.
7. Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997; 336: 243-250.
8. Easton KL, Mackson JM, Stanton LA, et al. Community-acquired pneumonia: towards improving outcomes nationally [abstract]. 8th World Congress on Clinical Pharmacology and Therapeutics. Brisbane, 1-6 August 2004.
9. National Health and Medical Research Council. When does quality assurance in health care require independent ethical review? Canberra: NHMRC, 2003. Available at: http://www.nhmrc.gov.au/publications/synopses/e46syn.htm (accessed Oct 2005).
10. Australian Institute of Health and Welfare. Australian hospital statistics 2001-02. Table A4.2. Health Services Series No. 20. Canberra: AIHW, 2001. (AIHW Catalogue No. HSE-25.) Available at: http://www.aihw.gov.au/publications/index.cfm/title/8881 (accessed Oct 2005).
11. Dobbin CJ, Duggan CJ, Barnes DJ. The efficacy of an antibiotic protocol for community-acquired pneumonia. Med J Aust 2001; 174: 333-337.
12. Victorian Drug Usage Evaluation Group. Antibiotic treatment of lower respiratory tract infection in emergency departments. Melbourne: VDUEG, 2003. Available at: http://www.health,vic.gov.au/vmac/vdue.htm (accessed Jul 2005).
13. Buising K, Thursky K, Black J, Brown G. Are the Australian guidelines asking too much of the Pneumonia Severity Index (PSI)? [letter] Med J Aust 2004; 180: 486-487.
14. Charles PGP, Whitby M, Fuller A, et al. The aetiology and severity of community-acquired pneumonia (CAP) - early results from the Australian community-acquired pneumonia study (ACAPS). The Australasian Society of Infectious Diseases Inc. Annual Scientific Meeting, Busselton, Western Australia, 9-13 April 2005.
15. State Coroner Victoria. Beware of the 'well' young patient. Coronial Communique 2005; 3(1): 2. Available at: http://www.vifm.org/inclsnewsletter.html (accessed May 2005).
16. Maxwell DJ, Kaye KI, Brien JE, Easton KL. Community-acquired pneumonia: ceftriaxone and penicillin - a global perspective [abstract]. 8th World Congress on Clinical Pharmacology and Therapeutics. Brisbane, 1-6 August 2004.
17. Andresen DN, Collignon PJ. Antibiotics for community-acquired pneumonia: time to return to the straight and narrow? Med J Aust 2001; 174: 321-322.
18. Paterson DL, Playford EG. Should third-generation cephalosporins be the empirical treatment of choice for severe community-acquired pneumonia in adults? Med J Aust 1998; 168: 344-348.
19. Dancer SJ. The problem with cephalosporins. J Antimicrob Chemother 2001; 48: 463-478.
20. Robertson MB, Korman TM, Dartnell JG, et al. Ceftriaxone and cefotaxime use in Victorian hospitals. Med J Aust 2002; 176: 524-529.
21. Marrie TJ. Empiric treatment of ambulatory community-acquired pneumonia: always include treatment for atypical agents. Infect Dis Clin North Am 2004; 18: 829-41.
22. Burgess DS, Lewis JS 2nd. Effect of macrolides as part of initial empiric therapy on medical outcomes for hospitalized patients with community-acquired pneumonia. Clin Ther 2000; 22: 872-878.
23. Stahl JE, Barza M, DesJardin J, et al. Effect of macrolides as part of initial empiric therapy on length of stay in patients hospitalized with community-acquired pneumonia. Arch Intern Med 1999; 159: 2576-2580.
24. Bero LA, Grilli R, Grimshaw JM, et al. Getting research findings into practice: closing the gap between research and practice: an overview of systematic reviews of interventions to promote the implementation of research findings. BMJ 1998; 317: 465-468.
25. Brown EM. Guidelines for antibiotic usage in hospitals. J Antimicrob Chemother 2002; 49: 587-592.